APLS — APELLIS PHARMACEUTICALS INC

Ownership history in Exome Asset Management LLC  ·  6 quarters on record

This page tracks every 13F SEC filing in which Exome Asset Management LLC reported a position in APELLIS PHARMACEUTICALS INC (APLS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
2.86% (2024 Q4)
Avg. % of fund
1.62%
First filed
2023 Q4
Last filed
2025 Q4
Quarters held
6
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 135,849 +37,249 +37.8% 1.63% $3.4M $25.12
2025 Q2 REDUCED 98,600 -20,867 -17.5% 1.27% $1.7M $17.31
2024 Q4 ADDED 119,467 +19,100 +19.0% 2.86% $3.8M $31.91
2024 Q3 ADDED 100,367 +53,467 +114.0% 1.99% $2.9M $28.84
2 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    APLS price (monthly, adj. close)

Other funds also holding APLS

As of 2025 Q4 — sorted by position size

Deep Track Capital, LP 3Y 3.47% Avoro Capital Advisors LLC 3Y 7Y 3.02% SUVRETTA CAPITAL MANAGEMENT, LLC 3Y 7Y 2.13% Siren, L.L.C. 1.93% RTW INVESTMENTS, LP 3Y 7Y 1.93% Logos Global Management LP 3Y 1.52% Kynam Capital Management, LP 3Y 1.46% ORBIMED ADVISORS LLC 3Y 7Y 1.25% SPHERA FUNDS MANAGEMENT LTD. 3Y 7Y 1.22% HighVista Strategies LLC 3Y 7Y 0.98%
← Back to Exome Asset Management LLC Holdings